Cell growth regulation of scirrhous gastric carcinoma.
K. Kuki,N. Takahashi,H. Takeda,G. Asano,T. Shoji
DOI: https://doi.org/10.1272/JNMS1923.55.94
1988-02-15
Abstract:In scirrhous carcinoma, cancer cell infiltration is demonstrated in abundant fibrous stroma'). The fibrous stromal formation may be induced by infiltrating cancer cells and mesenchymal cells, and fibroblasts may contribute to the production of extracellular connective tissue. Tumor cell and mesenchymal cell may synthesize various types of collagen and glycosaminoglycan. However the mechanism of intercellular influences between cancer cells and mesenchymal cells is not clearly understood. This study was undertaken to clarify the interactions between cancer cells and mesenchymal cells in scirrhous carcinoma of the human stomach. The MA IV cell line was established from a signet ring cell carcinoma of the human stomach, and was compared with the biological features of the MKN 28 cell line which was derived from a differentiated adenocarcinoma of the stomach. These cells were maintained in RPMI medium with 10% fetal bovine serum. Human fibroblasts were derived from the subcutaneous tissue of a healthily 3-year-old male and maintained in MEM medium with 10% fetal bovine serum. MA IV and MKN 28 cells were cultured for one week. The media were removed and filtrated with a 0.22 ,um filter unit, Millex-GV. Human skin fibroblasts were plated at 2.5 X 105 cells per well and cultured with 50% MEM and 50% tumor cell conditioned media. The number of cells was counted by culture counter on the 1st, 2nd, 6th, 10th and 12th day. As a control, the fibroblasts were cultured in tumor cell free media. The number of fibroblasts decreased in the MA IV, MKN 28 and control conditioned media on the first day and gradually increased from the second day. A 30% increase in the number of fibroblast was noted in MA IV conditioned medium compared with the other conditioned media on the 10th day (p<0.01) (Fig. 1-1). The MA IV cell line was cultured for 14 day in a type IV collagen solution (Cell matrix, Nitta Gelatine Co., Ltd., Osaka) containing Ham's F10, reconstitution buffer (2.2g NaHCO3 and 4.77g HEPES in 100ml of 0.05N NaOH) and 20% fetal bovine serum. The cells were then pulsely labelled with 100,ug bromodeoxyuridine (BrdU) (Becton Dickinson, Co., Ltd., USA). After 30 minutes of incubation, the labelled cells were fixed in 70% ethanol for 30 minutes and incubated in 4N HCI for 20 minutes. Subsequently 1:200 anti-BrdU (Becton Dickinson, Co., Ltd., USA) as special antibody, and 1:45 peroxidase conjugated anti mouse-IgG as secondary antibody were used. The BrdU positive cells were counted under a light microscope, and the results were estimated by t-test.